News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Campanelli Paul
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2022 |
4
| Campanelli Paul (Director) has filed a Form 4 on Convey Health Solutions Holdings, Inc.|
Txns:
| Disposed/sold 27,125 options to buy
@ $0 |
|
| 03/30/2022 |
4
| Campanelli Paul (Director) has filed a Form 4 on Convey Health Solutions Holdings, Inc.|
Txns:
| Granted 27,125 restricted stock units
@ $0 |
|
| 02/15/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/06/2021 |
4
| Campanelli Paul (Director) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 146,400 shares
@ $7.37, valued at
$1.1M
Exercised 300,000 shares
@ $0
Exercised 368,300 shares
@ $0
Paid exercise price by delivering 188,384 shares
@ $7.37, valued at
$1.4M
|
|
| 03/31/2021 |
4
| Campanelli Paul (Director) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 72,926 shares
@ $7.3129, valued at
$533.3k
|
|
| 08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2020 |
4
| Campanelli Paul (Director) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 146,400 shares
@ $3.16, valued at
$462.6k
|
|
| 03/31/2020 |
4
| Campanelli Paul (Director) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 72,926 shares
@ $3.52, valued at
$256.7k
|
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2019 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 1,874 shares
@ $3.12, valued at
$5.8k
|
|
| 08/13/2019 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 69,539 shares
@ $2.49, valued at
$173.2k
Paid exercise price by delivering 47,251 shares
@ $2.49, valued at
$117.7k
|
|
| 04/04/2019 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 146,400 shares
@ $8.1, valued at
$1.2M
|
|
| 04/02/2019 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Granted 448,318 shares
@ $0 |
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 24,184 shares
@ $10.38, valued at
$251k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2018 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 70,180 shares
@ $15.82, valued at
$1.1M
|
|
| 08/02/2018 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Granted 290,476 shares
@ $0 |
|
| 04/04/2018 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Granted 900,000 shares
@ $0 |
|
| 02/27/2018 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 942 shares
@ $6.78, valued at
$6.4k
|
|
| 02/22/2018 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 24,184 shares
@ $6.72, valued at
$162.5k
|
|
| 10/02/2017 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 1,330 shares
@ $8.38, valued at
$11.1k
|
|
| 08/15/2017 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Bought 6,500 shares
@ $7.71, valued at
$50.1k
|
|
| 08/11/2017 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc|
Txns:
| Granted 427,500 shares
@ $0
Granted 971,590 options to buy
@ $7.55, valued at
$7.3M
|
|
| 03/16/2017 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc |
| 02/27/2017 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc |
| 02/23/2017 |
4
| Campanelli Paul (President, CEO) has filed a Form 4 on Endo International plc |
| 09/28/2016 |
4
| Campanelli Paul (President & CEO) has filed a Form 4 on Endo International plc |
| 05/11/2016 |
4
| Campanelli Paul (Group President, Generics) has filed a Form 4 on Endo International plc|
Txns:
| Bought 13,000 shares
@ $15.53, valued at
$201.9k
|
|
| 02/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/12/2015 |
4
| Campanelli Paul (President, Par Pharmaceutical) has filed a Form 4 on Endo International plc|
Txns:
| Bought 1,900 shares
@ $55.62, valued at
$105.7k
Bought 200 shares
@ $56.38, valued at
$11.3k
Granted 2,100 shares
@ $0 |
|
| 11/05/2015 |
4
| Campanelli Paul (Group President, Generics) has filed a Form 4 on Endo International plc|
Txns:
| Granted 72,632 shares
@ $0 |
|
| 09/30/2015 |
4
| Campanelli Paul (Group President, Generics) has filed a Form 4 on Endo International plc|
Txns:
| Granted 15,367 shares
@ $0
Granted 30,734 shares
@ $0
Granted 56,920 options to buy
@ $61.82, valued at
$3.5M
|
|
| 10/02/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|